Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain

Condition:   Hawthorn Red Combined Refractory Cancer Pain Intervention:   Drug: Hawthorn red pigment Sponsor:   Fujian Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials